Proteomic characterization of novel serum amyloid P component variants from human plasma and urine
- 25 May 2004
- journal article
- research article
- Published by Wiley in Proteomics
- Vol. 4 (6) , 1825-1829
- https://doi.org/10.1002/pmic.200300690
Abstract
Serum amyloid P component (SAP) is a human plasma protein that has been widely studied for its influence on amyloid plaque formation and stabilization. SAP was characterized directly from human plasma and urine samples via novel affinity mass spectrometry-based proteomic technology that is able to readily discriminate between mass-altered protein variants. These analyses were able to identify several variants of SAP that have not been previously reported. These variants include microheterogeneity of the glycan structure, from the loss of one or both terminal sialic acid residues, as well as the loss of the C-terminal valine residue. Moreover, the analysis of urine allowed for the consistent identification of serum amyloid P component as a normal constituent of the urine proteome.Keywords
This publication has 13 references indexed in Scilit:
- Comparative Urine Protein Phenotyping Using Mass Spectrometric ImmunoassayJournal of Proteome Research, 2003
- Comparative phenotypic analyses of human plasma and urinary retinol binding protein using mass spectrometric immunoassayBiochemical and Biophysical Research Communications, 2002
- High-Throughput Analysis of Hemoglobin from Neonates Using Matrix-assisted Laser Desorption/Ionization Time-of-Flight Mass SpectrometryClinical Chemistry, 2002
- Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosisNature, 2002
- Determination of β-2 Microglobulin Levels in Plasma Using a High-Throughput Mass Spectrometric Immunoassay SystemAnalytical Chemistry, 2001
- Amyloid P component. A critical reviewAmyloid, 1997
- Peptide characterization using bioreactive mass spectrometer probe tipsRapid Communications in Mass Spectrometry, 1995
- The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo.Journal of Clinical Investigation, 1994
- Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure.Proceedings of the National Academy of Sciences, 1994
- The Role of Surface Carbohydrates in the Hepatic Recognition and Transport of Circulating GlycoproteinsPublished by Wiley ,1974